CryoPort, Inc. (CYRX.OB) on Thursday said it has named Stephen Wasserman, 65, to its Board of Directors. He replaces Carlton Johnson, who resigned from the Board earlier this month.
CryoPort provides cold chain frozen shipping systems primarily to the biotechnology, pharmaceutical, and life science industries. Wasserman has over 30 years of senior operating and financial management experience in the medical device and healthcare industries.
Wasserman is currently on the Board of the medical diagnostics firm Iris International and serves as chairman of the compensation committee.
Previously he was group vice president of the Diagnostic Systems Products division of medical technology firm Olympus America as well as a member of the executive committee for American Operations.
Larry Stambaugh, CryoPort's chairman and chief executive officer, said, "Stephen's experience managing highly successful medical device and diagnostic companies will be extremely valuable to CryoPort as we accelerate our commercial activities this year. We look forward to drawing on Stephen's in-depth knowledge of our target markets and his proven ability to drive the introduction of new technologies and products."
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org